Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Viral Genetics, Inc. is a biotechnology company that discovers and develops immune-based therapies for HIV and AIDS using its thymus nuclear protein compound. This compound may have other potential applications for other infectious, autoimmune, and immunological deficiency diseases that the company intends to study in the future. Viral Genetics believes that VGV-1 represents a significant and unique approach to treating HIV due to the apparently novel mechanism, low toxicity profile, simple dosing regimen, and short-course of treatment. Our management team, board and advisors include world-renowned experts in the fight against HIV/AIDS, infectious disease, and autoimmune ( www.viralgenetics.com )
Viral Genetics , Inc.
1321 Mountain View Circle
Azusa, California 91702
USA
Tel: (626) 334-5310
Fax: (626) 334-5324